These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3531034)

  • 21. Report of a double-blind crossover study of flurbiprofen and placebo in detrusor instability.
    Palmer J
    J Int Med Res; 1983; 11 Suppl 2():11-7. PubMed ID: 6347753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ; Cardozo LD; Versi E; Cooper D
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Marschall-Kehrel D; Feustel C; Persson de Geeter C; Stehr M; Radmayr C; Sillén U; Strugala G
    Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management of the unstable bladder.
    Younglove RH; Newman RL; Wall LA
    J Reprod Med; 1980 May; 24(5):215-8. PubMed ID: 7401053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence.
    Sole GM; Arkell DG
    Scand J Urol Nephrol Suppl; 1984; 87():55-7. PubMed ID: 6399955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
    Nijman RJ; Borgstein NG; Ellsworth P; Djurhuus JC
    J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence.
    Ek A; Andersson KE; Gullberg B; Ulmsten U
    Zentralbl Gynakol; 1980; 102(15):839-44. PubMed ID: 7006273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
    Rios LA; Panhoca R; Mattos D; Srugi M; Bruschini H
    Neurourol Urodyn; 2007; 26(6):773-8. PubMed ID: 17638305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of fentonium bromide in Indonesian volunteers.
    Wilmana PF; Istiantoro J; Sinto A; Darmansjah I
    Curr Med Res Opin; 1977; 5(3):284-8. PubMed ID: 162668
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind controlled trial of the new preparation FZ. 560 in the symptomatic treatment of digestive disorders.
    Porsio A; Borgia M
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):40-3. PubMed ID: 61952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of urinary urge incontinence with clenbuterol (author's transl)].
    Koch J; Günther KP; Steinberger H
    Dtsch Med Wochenschr; 1980 May; 105(20):724-7. PubMed ID: 7371552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline.
    Coombes GM; Millard RJ
    Med J Aust; 1996 Nov; 165(9):473-6. PubMed ID: 8937366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of phenylpropanolamine on female stress urinary incontinence.
    Lehtonen T; Rannikko S; Lindell O; Talja M; Wuokko E; Lindskog M
    Ann Chir Gynaecol; 1986; 75(4):236-41. PubMed ID: 3535621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
    Yamaguchi O; Marui E; Kakizaki H; Itoh N; Yokota T; Okada H; Ishizuka O; Ozono S; Gotoh M; Sugiyama T; Seki N; Yoshida M;
    BJU Int; 2007 Sep; 100(3):579-87. PubMed ID: 17669143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
    Davila GW; Daugherty CA; Sanders SW;
    J Urol; 2001 Jul; 166(1):140-5. PubMed ID: 11435842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
    Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
    Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravaginal stimulation randomized trial.
    Smith JJ
    J Urol; 1996 Jan; 155(1):127-30. PubMed ID: 7490809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes induced by Mictonorm in the urodynamics of the detrusor muscle in females with symptoms of the urge to urinate].
    Höfner K; Dorschner W; Höfner T; Dieterich F
    Z Urol Nephrol; 1985 Jul; 78(7):363-70. PubMed ID: 4050155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.